Publication:
Colon-Specific Delivery of Nutraceuticals

dc.authorscopusid57213623355
dc.authorscopusid57218213926
dc.authorscopusid22981136400
dc.authorscopusid16548780200
dc.contributor.authorKrishnamoorthy, S.
dc.contributor.authorZongo, K.
dc.contributor.authorMoses, J.A.
dc.contributor.authorAnandharamakrishnan, C.
dc.date.accessioned2025-12-11T00:31:17Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Krishnamoorthy] Srinivasan, Computational Modeling and Nanoscale Processing Unit, National Institute of Food Technology, Entrepreneurship and Management, Thanjavur, Thanjavur, TN, India; [Zongo] Koka, Food Engineering Department, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Moses] J. A., Computational Modeling and Nanoscale Processing Unit, National Institute of Food Technology, Entrepreneurship and Management, Thanjavur, Thanjavur, TN, India; [Anandharamakrishnan] C., Computational Modeling and Nanoscale Processing Unit, National Institute of Food Technology, Entrepreneurship and Management, Thanjavur, Thanjavur, TN, India, National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram, KL, Indiaen_US
dc.description.abstractAiming at the targeted delivery of nutrients to the intestinal region, designing and developing novel colon-specific delivery systems has attracted increasing interest in the recent past. Nevertheless, there are many challenges in delivering nutrients to the distant organ, which requires advanced strategies. Although traditional designing methods such as pellets and granules remain viable approaches with limitations, nanoscience offers superior advantages in stabilizing the growing nutraceutical formulations and enhancing its nutrient absorption and bioavailability. This chapter also discusses the challenges in targeted colon delivery through gastrointestinal tissues such as pH, colonic microflora, enzymes, and other epithelial barriers. Further, the recent advances in vitro gastric models for testing the rising formulation candidates specific to nutraceuticals and probiotic supplements with colon-specific health claims are highlighted. Lastly, we provide the pertinent issues that hinder the effective preservation and maximization of the nutrient’s bioactivity and safety of these new nutraceutical carrier systems inside the human body. © 2023 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/B978-0-12-824312-1.00012-1
dc.identifier.endpage432en_US
dc.identifier.isbn9780323859806
dc.identifier.isbn9780128243121
dc.identifier.scopus2-s2.0-85176858658
dc.identifier.startpage397en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-12-824312-1.00012-1
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36957
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBioavailabilityen_US
dc.subjectColon-Targeted Nutrient Deliveryen_US
dc.subjectMicro/Nanocarrier Systemsen_US
dc.subjectTherapeutic Nutraceuticalsen_US
dc.titleColon-Specific Delivery of Nutraceuticalsen_US
dc.typeBook Parten_US
dspace.entity.typePublication

Files